CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 14.85% on an annualized basis producing an average annual return of 28.2%. Currently, CRISPR Therapeutics has a market capitalization of $4.51 billion.
Buying $1000 In CRSP: If an investor had bought $1000 of CRSP stock 5 years ago, it would be worth $3,530.16 today based on a price of $58.53 for CRSP at the time of writing.
